CR20140051A - BENCEN-SULFONAMIDE TIAZOL AND OXAZOL COMPOUNDS - Google Patents

BENCEN-SULFONAMIDE TIAZOL AND OXAZOL COMPOUNDS

Info

Publication number
CR20140051A
CR20140051A CR20140051A CR20140051A CR20140051A CR 20140051 A CR20140051 A CR 20140051A CR 20140051 A CR20140051 A CR 20140051A CR 20140051 A CR20140051 A CR 20140051A CR 20140051 A CR20140051 A CR 20140051A
Authority
CR
Costa Rica
Prior art keywords
sulfonamide
bencen
tiazol
oxazol
compounds
Prior art date
Application number
CR20140051A
Other languages
Spanish (es)
Inventor
Jerry Leroy Adams
Scott Howard Dickerson
Neil W Johnson
Kevin Kuntz
Kimberly Petrov
Jeffrey M Ralph
Tara Renae Rheault
Gregory Schaaf
John Stellwagen
Xinrong Tian
David Edward Uehling
Alex Gregory Waterson
Brian Wilson
George Adjabeng
Keith Hornberger
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Priority to CR20140051A priority Critical patent/CR20140051A/en
Publication of CR20140051A publication Critical patent/CR20140051A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuestos de tiazol-sulfonamida y de oxazol-sulfonamida, composiciones que los contienen, procesos para la preparación y métodos para su uso como agentes farmacéuticos.Thiazol-sulfonamide and oxazol-sulfonamide compounds, compositions containing them, processes for the preparation and methods for use as pharmaceutical agents.

CR20140051A 2014-01-29 2014-01-29 BENCEN-SULFONAMIDE TIAZOL AND OXAZOL COMPOUNDS CR20140051A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR20140051A CR20140051A (en) 2014-01-29 2014-01-29 BENCEN-SULFONAMIDE TIAZOL AND OXAZOL COMPOUNDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR20140051A CR20140051A (en) 2014-01-29 2014-01-29 BENCEN-SULFONAMIDE TIAZOL AND OXAZOL COMPOUNDS

Publications (1)

Publication Number Publication Date
CR20140051A true CR20140051A (en) 2014-05-16

Family

ID=50884158

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140051A CR20140051A (en) 2014-01-29 2014-01-29 BENCEN-SULFONAMIDE TIAZOL AND OXAZOL COMPOUNDS

Country Status (1)

Country Link
CR (1) CR20140051A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022036176A1 (en) * 2020-08-13 2022-02-17 Albert Einstein College Of Medicine N-cyclyl-sulfonamides useful for inhibiting raf
US12331026B2 (en) 2022-03-28 2025-06-17 Nikang Therapeutics, Inc. Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022036176A1 (en) * 2020-08-13 2022-02-17 Albert Einstein College Of Medicine N-cyclyl-sulfonamides useful for inhibiting raf
US12331026B2 (en) 2022-03-28 2025-06-17 Nikang Therapeutics, Inc. Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors

Similar Documents

Publication Publication Date Title
CL2017003205A1 (en) New bicyclic derivatives, a process for their preparation and pharmaceutical compositions that contain them.
CO2018005369A2 (en) Triazole acc inhibitors and uses thereof
SV2018005794A (en) USEFUL REPLACED CARBONUCLEOSIDE DERIVATIVES AS ANTHINEOPLASTIC AGENTS
SV2018005792A (en) NEW PIPERIDINYL DERIVATIVES REPLACED WITH HETERO (ARILO), A PROCESS FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GT201700189A (en) DERIVATIVES OF USEFUL REPLACED NUCLEOSIDS AS ANTINEOPLASTIC AGENTS
CL2018003474A1 (en) New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them.
CO2017001994A2 (en) Active compounds towards bromodomains
SV2017005590A (en) NEW HYDROXIACIDE DERIVATIVES A PROCESS FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DOP2017000078A (en) INDAZOLS REPLACED WITH BENCILO AS INHIBITORS OF BUB1.
CL2016002877A1 (en) Compounds of 2-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine, compositions and methods of use thereof.
CL2015002891A1 (en) Deaza-macrocyclic purinones for the treatment of viral infections.
GT201700023A (en) OPTIONALLY CONDENSED HYDERO-CYCLIC DERIVATIVES OF PIRIDIMINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOINMUNITY DISEASES
CL2016001973A1 (en) Nucleoside derivatives substituted with 4'-difluoromethyl as inhibitors of influenza arn replication.
CL2014001793A1 (en) Compounds derived from substituted 1,3,5-triazines and their salts, as inhibitors of mutant idh2; pharmaceutical composition that includes them; and its use for the treatment of cancer.
PT3177659T (en) COMPOUNDS CONTAINING NITROGEN, SUITABLE FOR USE IN THE PREPARATION OF POLYURETHANES
NI201400079A (en) NEW PIRROL DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
UY34669A (en) COMPOUNDS BASED ON IMIDAZO [1,2-b] PIRIDAZINE, COMPOSITIONS THAT INCLUDE THEM AND METHODS FOR USE.
UY34632A (en) OXAZOLIDIN- 2- ONA COMPOUNDS AND USES OF THE SAME
CL2017001923A1 (en) 9h-pyrrolo-dipyridine derivatives
ES2897914T8 (en) Nitrogen-containing compounds, suitable for use in the production of polyurethanes
AR125920A2 (en) COMPOSITIONS COMPRISING VORTIOXETINE AND DONEPEZIL
CL2016003074A1 (en) Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer.
MX2018002416A (en) DERIVATIVES OF 1,7-DIARIL-1,6-HEPTADIEN-3,5-DIONA, PROCEDURE FOR THE PREPARATION AND USE OF THE SAME.
CL2016000038A1 (en) Pyroxolo-substituted pyridinamines
UY36117A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFECTIOUS DISEASES.